Atlas Trials

Clinical Study of F61 Injection in Healthy Chinese Subjects

Clinical trial NCT05483504 · UNKNOWN

Trial details

NCT number
NCT05483504
Sponsor
Wuhan Institute of Biological Products Co., Ltd
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2022-08-01
Primary completion
2022-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.